Trial Profile

A Phase II Trial of Clofarabine in Older Patients With Acute Myeloid Leukemia for Whom Intensive Chemotherapy is Not Considered Suitable.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 21 Jun 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Clofarabine (Primary)
Indications Acute myeloid leukaemia
Focus Therapeutic Use
Sponsors Bioenvision

Most Recent Events

14 Aug 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
20 Jun 2009 Actual initiation date (Jun 2004) added, patient numbers amended from 66 to 69, Genzyme Corporation added as affiliate and sponsor, additional locations, additional primary endpoint as overall response rate as reported by ClinicalTrials.gov.
20 Jun 2009 Actual end date (Mar 2008) added as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com